tradingkey.logo
搜索

波士顿科学

BSX
添加自选
44.205USD
-0.255-0.57%
收盘 06/25, 16:00美东报价延迟15分钟
65.70B总市值
18.39市盈率 TTM

关于 波士顿科学 公司

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

波士顿科学简介

公司代码BSX
公司名称Boston Scientific Corp
上市日期May 19, 1992
CEOMahoney (Michael F)
员工数量53000
证券类型Ordinary Share
年结日May 19
公司地址300 Boston Scientific Way
城市MARLBOROUGH
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编01752-1234
电话15086834000
网址https://www.bostonscientific.com/en-US/Home.html
公司代码BSX
上市日期May 19, 1992
CEOMahoney (Michael F)

波士顿科学公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
45.38K
+8.37%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
13.88K
+59.45%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
--
Mr. Joseph M. Fitzgerald
Mr. Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiology
Executive Vice President, Group President - Cardiology
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
45.38K
+8.37%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%

常见问题

波士顿科学的前五大股东是谁?

波士顿科学 的前五大股东如下:Mr. Michael F. (Mike) Mahoney

有多少机构持有波士顿科学(BSX)的股份?

截至2026Q1,共有3113家机构持有波士顿科学的股份,合计持有的股份价值约为1.40B,占公司总股份的94.35%。与2025Q4相比,机构持股有所增加,增幅为-15512534.00。

哪个业务部门对波士顿科学的收入贡献最大?

在2026Q1,Interventional Cardiology Therapies业务部门对波士顿科学的收入贡献最大,创收4.64B,占总收入的23.11%。
KeyAI